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1. INTRODUCTION  
 
1.1 Dietary life-style: Western Diet vs High Fat Diet 
Extensive scientific evidence indicating that non-optimal diet and sedentary lifestyle constitute 
some of the behaviors /risk factors  associated with the onset of many diseases with significant 
societal impact, such as inflammatory bowel disease (IBD) and obesity(1;2). On the contrary, the 
maintaining a balance between physical activity and dietary energy intake is an effective and safe 
way to prevent these clinical problems, as well as their economic impact.  For this reason, numerous 
official recommendations and education campaigns to sensitize people towards healthy dietary 
behaviors have been established. Despite these recommendations, IBD and obesity have risen in 
incidence at an alarming rate over the past decade and are now two of the most serious worldwide 
health problems. Particularly alarming is the marked increase in obesity among children. The World 
Health Organization reports that at least 2.8 million people die each year as a result of being 
overweight or obese, and about 150-200 cases per 100000 from intestinal cancer (3;4;5). 
A Western-style diet (WD), defined by elevated fat (20%), low calcium and low vitamin D content, 
is associated with increased risk of human intestinal cancer (6). A defined rodent WD, formulated 
by Newmark and M.Lipkinic, reflecting dietary patterns linked to elevated intestinal cancer 
incidence has been demonstrated to cause neoplastic lesions when fed to wild-type mice for at least 
1 year (7;8). Most of the studies mainly investigate the link between WD and colon tumors. Yet 
little is known about regarding the induction of small intestine tumors. The small intestine is a 
relatively rare site for primary gastro-intestinal (GI) tract cancer, yet nonetheless recent studies 
show an increasing incidence of small intestine adenocarcinoma (SIAC) (9;10). 
High fat diet, consisting of 60% Kcal from fat, predisposes mice to the development of obesity and 
other pathological consequences. This allows the study of a wider spectrum of human metabolic 
disease as well as its associated inflammation in the visceral compartment, that leads to adipose 
tissue dysfunction (2;11).  
 
1.2 Defense mechanisms in the gastrointestinal tract. 
The intestinal epithelium has a vast surface area that is continuously exposed to dietary and 
microbial antigens. These antigens need to be tolerated to maintain homeostasis, but pathogens 
must also be prevented from harming the host. The first line of defense is represented by the   
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mucosal barrier while the second line by the immune component constituted by the Gut associated 
lymphoid tissue (GALT), which includes lymphocytes and phagocytes.   
 
1.3 Intestinal mucosa barrier  
The intestinal epithelium is a delicate structure organized into invaginations called the crypts of 
Lieberkuhn and fingerlike protrusions called villi. It is composed of a columnar monolayer of 
polarized cells, the enterocytes, and other specialized differentiated cell types: goblet cells, 
neuroendocrine cells, Paneth cells and M cells that all originate from common intestinal epithelial 
stem cells. The organization of the epithelium in the small intestine and the colon is similar. 
However, histologically there are three important differences: the colon carries no villi but has a flat 
surface epithelium and Paneth cells are absent (12). The intestine, in addition to processing and 
absorbing dietary nutrients, performs other functions that are critical for intestinal homeostasis. 
Goblet cells produce and secrete glycosylate mucins that block the direct attachment of microbiota 
to the epithelium, thereby spatially regulating the colonization of commensal bacteria (13).  Defects 
in mucus production alter the morphology of epithelial cells, which results in spontaneous colitis 
(14). The spatial separation of bacteria from the epithelial surface is further supported by secretion 
of antimicrobial peptides, such as lysozymes and defensins, secreted by Paneth cells. These cells 
reside near the stem cell crypt in the villi of the small intestine and can directly sense commensal 
microbiota through a TLR-MyD88 pathway. More intriguingly, Paneth cells provide essential niche 
signals to intestinal stem cells and cooperate with the latter to sustain the physiological self-renewal 
of the small intestine (15;16). The precise control of cell renewal along the cript-villus axis is 
regulated by different pathways that include WNT, Hedgehog and Notch (17).  The Wnt signaling 
pathway is the dominant mechanism underlying the proliferative activity of the intestinal 
epithelium. The central player in the canonical Wnt pathway is β-catenin. In the absence of a Wnt 
signal, β-catenin is targeted for proteasomal degradation through a dedicated destruction complex 
that consists of adenomatous polyposis coli (APC), casein kinase I (CKI), glycogen synthase kinase 
3 (GSK3), and axin. Signalling by WNT factors (Wnt ligands bind to Frizzled receptors and low-
density lipoprotein receptor–related protein (LRP) coreceptors) inhibits the APC complex. As a 
result, β-catenin is stabilized in the cytoplasm and translocates into the nucleus, where it interacts 
with nuclear TCF transcription factors to drive the transcription of specific target genes (12; 18;19).  
Aberrant activation of WNT signaling has been directly linked to the development of colon-rectal 
cancer (20;21). Mice deficient for the TCF-4 completely fail to maintain the stem cells 
compartment in the fetal small intestinal epithelium (22). Moreover, disruption of EphB2 and 
EphB3 genes results in redistribution of proliferative cells within the crypt (23;24).  
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                                                                                    Lance W. Peterson & David Artis, Nature Reviews Immunology 2014 
 
 
Fig.1: Organization of the intestinal epithelium  
 
1.4 Microbiota and Pattern Recognition Receptors (PRRs) 
The total microbial load of the intestine, 10
13–1014 microorganisms, collectively contain at least 100 
times as many genes as the human genome. These bacteria increase in both concentration and 
complexity from the proximal gastric to the colon. Greater than 99% of the gut microbiota is 
composed of species within 4 bacterial divisions: Firmicutes, Bacteroidetes, Proteobacteria, and 
Actinobacteria (25). The microbiota is generally viewed as being stable during adult life, during 
which establish a complex relationship with the host, resulting in the modulation of host physiology 
and metabolism, and it provides a natural defense against invading pathogens (26).  
The physiological importance of the gut microbiota in intestinal development and homeostasis 
raises the question of how the host senses the myriad of microbial organisms. Two major classes of 
receptor have been identified that are integral to the host response to bacteria: the Toll-like 
receptors (TLRs) and the Nod-like receptors (NLRs). Pattern Recognition Receptors (PRRs) are 
mainly expressed by various immune cells, such as macrophages and dendritic cells, but their 
expression in intestinal epithelial cells (IEC) has also been reported (27;28;29). Although TLRs and 
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NLRs differ in their mode of pathogen recognition and function, they share similar domains for 
microbial sensing and cooperate to elicit immune responses against the pathogen. The TLR family 
consists of more than 13 members. Structurally, all TLRs are type I integral membrane proteins 
consisting of an ectodomain comprised of leucine-rich repeats (LRRs) and a cytoplasmic domain 
containing a Toll/IL-1R homology (TIR) domain, which is required for signaling. In general, TLR-
2,-4,-5 and -9 are the ones that recognize bacterial components. Specifically, TLR-2 recognizes 
peptidoglycan, lipoproteins contained in the cell wall of bacteria, TLR-4 recognizes 
lipopolysaccharides (LPS), contained in the cell wall of gram-negative bacteria, TLR-5 binds 
flagellin from bacteria, and TLR-9 recognize non–methylated CpG DNA, abundantly contained in 
bacterial DNA (30).  
The NLR family is composed of 23 cytosolic proteins characterized by 3 domains: a leucine-rich 
repeats (LRR) domain utilized for ligand sensing, a NATCH domain required for self-
oligomerization and activation, and an effector domain at the N-terminus that mediates interactions 
with other signaling proteins. In particular an NRL family member, NOD2/CARD15, recognizes 
the smallest fragment common to both Gram-negative and Gram-positive bacteria: the 
muramyldipeptide N-acetylmuramoyl-L-alanyl-D-glutamate (31). 
The activation of TLRs/NLRs is dependent upon the recruitment and association of adaptor 
molecules, such as Myeloid Differentiation factor 88 (MyD88), TIRAP, TRIF, or TRAM that 
provide the necessary framework to recruit and activate downstream kinases and transcription 
factors that regulate the host inflammatory response (32).   
The context of PRR activation is crucial. In the healthy intestine, basal PRRs activation promote 
epithelial cells proliferation, secretion of IgA into the Gut lumen and expression of antimicrobial 
peptides, but aberrant PRR activation may lead to IBD (33).  
The precise etiology of IBD remains unclear, but several factors that make a major contribution to 
disease pathogenesis have been identified: genetic factors, the host immune system, and 
environmental factors such as diet.  
On the other hand, epidemiological studies have identified diet as a major variable that contributes 
to the diversity of human gut microbiota. Altered composition of luminal microbiota is often 
accompanied by an alteration in immune response and may increase susceptibility to inflammation-
induced cancer, in particular intestinal cancer (34,35). Moreover different experimental models 
demonstrated that PRRs can contribute to development or protection of malignancy. The studies 
using TLR2 deficient mice showed that TLR2 signaling play a protective role against the 
development of colorectal cancer (36). In addition, TLR5/MyD88 signaling has been shown to 
reduce tumor size in a mouse xenograft model for CRC. A role of TLRs in colon carcinogenesis 
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was demonstrated by Fukata who showed that mice deficient in TLR4 were protected against the 
development of neoplasia by AOM and DSS (37).  
The functions of NLRs in the immune defense of the epithelium are only recently beginning to 
emerge. There is recent evidence that members of the NLR family play important roles in the 
immune response against invading pathogens and that NLR genetic variation causes or contributes 
to the development of inflammatory disorders or increased susceptibility to microbial infection. 
Indeed, Several mutation in the CARD/NOD2 gene have been associated with increased risk of 
intestinal cancer (38). 
 
                                                                                                                             R.Balfour Sartor, Gastroenterology 2008 
 
Fig.2: TLRs/NLRs signaling pathways 
 
1.5 The Gut associated lymphoid tissue (GALT) 
The intestinal epithelium is populated by a large and diverse community of immune cells that are 
intimately associated with intestinal epithelial cells (IECs). This immunological network, termed 
the gut associated lymphoid tissue (GALT), consists of unique arrangements of B cells, T cells and 
Phagocytes. The GALT comprises four distinct lymphoid compartments: the Peyer’s patches, the 
lymphoid follicles associated with the lamina propria, intraepithelial lymphocytes (IELs) and 
mesenteric lymph nodes (MLN). These lymphoid aggregates come into contact solely with antigens 
from the gut lumen and serve as sites of induction for intestinal immune responses.  
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Recent advances have begun to shed light on the role of adaptive immune pathways in the aberrant 
intestinal inflammatory response in patients with IBD (39). While Crohn’s disease (CD) has long 
been considered to be driven by a classical (Th1) response, ulcerative colitis (UC) has been 
associated with an alternative (Th2) response (40). Whilst there is no doubt that Th1 and Th2-
polarized responses are key drivers of intestinal inflammation, the additional contribution of other 
subsets of T cells, namely regulatory T (Treg) and Th17 still needs to be fully elucidated.  
Regulatory T (Treg) cells, characterized by the expression of the transcription factor Foxp3, are a 
functionally distinct, immunosuppressive T cell subpopulation that is thought to be engaged in 
sustaining immunological tolerance and homeostasis (41).  
Several groups have undertaken association studies in patients with IBD to provide whether 
changes in Treg cells can be correlated with disease. Some studies found that patients with CD or 
UC have decreased numbers of peripheral suppressive CD4+ CD45RO+ CD25+ FOXP3+ Treg 
cells during active disease, suggesting that the severity of disease is inversely correlated with the 
frequency of peripheral Treg cells (42-44). In contrast, other studies have found that the lamina 
propria, mesenteric lymph nodes and intestinal inflamed mucosa of patients with either CD or UC 
contain increased numbers of Treg cells compared with healthy controls (45;46). The elucidation of 
the factors regulating Treg localization during immune responses and how they control intestinal 
inflammation will be key for future therapeutic treatments. 
The Th17 subset is a recently-described proinflammatory T helper cell lineage that produces IL-17 
and IL-22 to eliminate specific types of pathogens that require a strong inflammatory response.  
However, an exaggerated Th17 response can give rise to chronic inflammation and autoimmune 
disorders (47;48).These T cells are thus potent effectors of inflammation, but little is known about 
the requirements for their differentiation. Consistent with this notion, Ivanov et al. demonstrated 
that specific commensal microbiota are required for Th17 cell differentiation in the lamina propria 
of the small intestine. In addition their results suggest that the microbiota regulate the balance 
between Th17 and Treg cells in the intestinal mucosa and may thus influence intestinal immunity 
and susceptibility to IBD (49). Moreover, it has been reported that CD4 T cells express TLRs and 
respond directly to TLR ligands. This suggests that the activation of antigen-specific immune 
responses is controlled by innate immune recognition (50). It is thus possible that alterations of the 
microbiota induced by diet may affect components of adaptive mucosal immunity and contribute to 
the pathophysiology of IBD. Elucidation of the specific role of distinct intestinal microbial species 
in the regulation of the balance and function of different helper T cell populations, will offer a 
greater understanding of how the intestinal host-microbial relationship regulate host defense and 
inflammation.   
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                                                                                                                                  Izcue A. et al,Annual Review of Immunology 2009 
 
Fig.3: Intestinal immune environment.  
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1.6 White Adipose tissue (WAT) 
Research over the past two decades has revealed that adipose tissue is a passive site of energy 
storage. Yet recently it has emerged that adipose tissue is also an important endocrine and metabolic 
organ as well as a key player in immunity and inflammation. This dynamic tissue is composed not 
only of adipocytes, but also of other cell types including stromal-vascular cells and immune cells 
and  it is surrounded  by supporting connective tissue that is highly vascularized and innervated. As 
an endocrine organ, adipose tissue is responsible for the synthesis and secretion of several 
hormones, known as adipokines, that are implicated in the regulation of many tissue response 
including hypothalamus, pancreas, liver, skeletal muscle, kidneys (51,52). 
 
 
Coelho et al, Arch Med Sci 2013 
 
Fig.4: Physiological functions of WAT. 
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1.7 Obesity and inflammation 
The qualitative and quantitative changes in the intake of specific food components have 
consequences not only on the composition of gut microbiota, but may also modulate the expression 
of genes in the adipose tissue, liver and skeletal muscle (53). These tissues readily buffer excess 
nutrients by storing them as triglycerides and glycogen. Chronic over-nutrition dramatically 
remodels adipose tissue architecture, driving adipocyte hypertrophy, oxidative stress and immune 
cell infiltration, followed by increased production of proinflammatory adipokines and cytokines that 
contribute to the progression of a chronic, low-grade inflammatory state (2). Obesity is associated 
with this inflammatory phenotype and increases the risk of chronic disease, including 
cardiovascular disease, as well as insulin resistance that predisposes to developing type 2 diabetes 
(4). These obesity-associated diseases are subsequently linked to premature death, and reinforce the 
need to further define the complex relationship between inflammation and adipose tissue 
dysfunction.  
Different studies have identified several candidates for inducers of metabolic inflammation such as  
endoplasmic reticulum stress due to excess lipid burden (54), hypoxia due to decreased oxygen 
diffusion into enlarged adipocytes (55), and toll-like receptor activation through free fatty acid 
sensing (56). In the mid-90s, an important role for inflammatory mediators, in particular TNF-α and 
IL-6, was revealed, and in ensuing years an active participation by macrophages was described 
(57;58). In healthy adipose tissue dispersed macrophages display an alternatively activated (M2) 
anti-inflammatory phenotype and promote insulin sensitivity in adipocytes by secreting IL-10(59). 
Positive energy balance, such as during diet-induced obesity (DIO), lead to increased macrophage 
infiltration and shifts toward the classical pro-inflammatory (M1) state. M1 macrophages aggregate 
around necrotic adipocytes, forming “crown-like structures” and produce pro-inflammatory 
cytokines perpetuating WAT inflammation and dysfunction contributing to the induction of insulin 
resistance (60). However, Fujisaka et al have demonstrated that the number of M2 macrophages 
was also increased in mice fed with HFD. The primary trigger for the recruitment of M1 
macrophages is thought to be the secretion of TNF-α from adipocytes (61). In contrast, the precise 
mechanism of how the increase of M2 macrophages is induced in diet-induced obese mice is not 
fully understood. These changes in the inflammatory phenotype of macrophages imply that other 
immune cells, such as T cells, may also participate in WAT inflammation (62,63). However, 
although T lymphocytes are known to interact with macrophages and regulate the inflammatory 
cascade, the specific contribution of the different lymphocyte subsets and their cytokines in obesity-
induced adipocytes inflammation remains unclear. Nishimura et al showed that CD8+ T cell 
infiltration is required for adipose tissue inflammation and precedes the accumulation of 
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macrophages (64). Recent reports demonstrate that during obesity the infiltrating CD4 T cells 
display a Th1 pattern of activation with enhanced interferon-γ production, and that an imbalance 
may exist in obese adipose between dominant Th1 responses and reduced Treg or Th2 responses 
(65-67). Additionally, understanding how T cells are recruited to adipose tissue and activated in 
obesity as yet to be investigated. The interaction between T cells and adipocytes is multi-faceted: 
several chemokines and cytokines have been implicated in the recruitment and activation of 
lymphocytes to the WAT, but a recent report suggests also that adipocytes themselves may be 
important antigen presenting cells that influence T cell activation in obesity (68). 
A better understanding of the crosstalk between metabolism and inflammation may optimize 
clinical interventions and lifestyle changes to improve human health.  
The Council on Science and Public Health of the American Medical Association (AMA) 
“recognize(s) obesity as a disease state with multiple pathophysiological aspects requiring a range 
of interventions to advance obesity treatment and prevention”.  
Reducing inflammation may thus represent a feasible disease-prevention strategy for obesity. 
 
 
 
 
                                                                                                                                                              Catalan et al, Front. Physiol.2013 
 
 
Fig. 5: Adipose tissue dysfunction 
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2. AIM OF THE STUDY: 
 
The aim of the first part of my work was to investigate a putative role for TLRs/NLRs in triggering events 
that lead to alteration of the small intestinal mucosa associated with consumption of Western Diet (WD).  
In the second part of my work, the aim was to evaluate the effects of X73, a commercial small-molecule anti-
inflammatory (the structure of which we cannot disclose in this dissertation for Intellectual Property reasons) 
in a mouse model of diet-induced obesity (DIO). In particular we analyzed the metabolic and inflammatory 
status and adipose tissue changes in mice fed with high fat diet (HFD) compared with mice fed with standard 
diet (SD), and how these events were modified as a result of treatment with X73.  
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3. MATERIALS AND METHODS 
 
3.1 Mice and Western diet 
C57BL/6J female and male mice at 8 weeks of age deficient for TLR2, 4, 9, or NOD2 and 
C57BL/6J wild-type (WT) mice fed with both standard (SD; AIN-76A ) and  Western Diet 
(WD;D16365B) have been used. The animals were separated in ten groups as follows: animals fed 
with WD (TLR2* KO, 4*KO, 9 *KO, NOD 2* KO and WT*) and animals fed with SD (TLR2 KO, 
4 KO, 9 KO, NOD2 KO and WT). Mice were monitored daily and weighed weekly. Five mice for 
group were anesthetized by prolonged CO2 treatment and sacrificed by cervical dislocation at 3, 6 
and 12 months feeding the diets. We will use the WD that has the same high levels of fat (20%) and 
low calcium and vitamin D of the WD originally formulated by Newmark and Lipkin and reflects 
dietary patterns linked to human intestinal cancer incidence (7).  
 
3.2 Mice and High Fat Diet 
We have used C57BL/6J female mice at 8 weeks of age. Ten animals were fed with SD (SD, AIN-
76A) and 30 mice were fed with High Fat Diet (HFD, D12492) for three months. Then, for other 
two months, only the mice fed with HFD were separated in four groups as follows: 9 animals 
continued to be fed with HFD, 7 animals returned to SD, 7 animals continued to be fed with HFD 
and 7 returned to SD but they received 30mg/kg of X73, a commercial small-molecule anti-
inflammatory treatment (the structure of which we cannot disclose in this dissertation for 
Intellectual Property reasons) in their drinking water. The water was changed every third day to 
maintain dosage. Body weight was monitored weekly. At the end of the experiment the mice were 
anesthetized by prolonged CO2 treatment and sacrificed by cervical dislocation.  
 
3.3 Processing of samples 
After collection, the adipose tissue and small intestine tissue samples were fixed in 4% formalin at 
4°C o/n. Then we proceeded with 2 rinses in PBS half-hour after each and were placed in 70% 
ethanol for at least 12 hours. Finally the samples were dehydrated by successive steps in an 
ascending scale of alcohols, placed in xylene for 2 hours and finally embedded in paraffin and 
sectioned at 3µm.  
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3.4 Hematoxylin and eosin staining (H&E) 
Hematoxylin-eosin staining was performed on sections obtained from paraffin-embedded samples. 
The samples were deparaffinized in xylene, rehydrated through descending scale of alcohol, left for 
5 minutes in hematoxylin, washed under running water and then placed in eosin for 6 minutes. After 
washing the sections were dehydrated through ascending scale of alcohols and xylene and then 
mounted with coverslips using Eukitt (Sigma). All samples were observed and photographed with a 
microscope Olympus BX53 with a digital camera. 
 
3.5 Ki67 immunohistochemistry 
The intestinal sections on slides are deparaffinized in xylene and hydrated through descending scale 
of alcohol. Antigen retrieval was performed by boiling sections for 10’ in 0,005M sodium citrate 
buffer (pH 6) in a microwave oven. Endogenous peroxidase was blocked by incubation with 3% 
H2O2, 50% methanol solution in PBS 1x 20’ at room temperature (RT), after which the sections 
were washed with PBS 1x (three washes of 5 minutes each). Sections were incubated with primary 
antibody anti-Ki67 (rat anti-mouse, Dako TEC-3) 1:50 in PBS for 30’ at RT, followed by 3 washes 
for 5 minutes with PBS 1x. After washing, the sections were incubated with biotinylated secondary 
antibody rabbit anti-rat 1:100 (Abcam, 6733) diluted in PBS 1x for 30’ minutes at RT. We 
proceeded with further washes for 5 minutes with PBS 1x, then the sections were incubated with 
ABC-kit (Vector) and immunoreactivity was visualized with 3,3-diaminobenzidine (DAB ,Biocare 
Medical). The development has been blocked with distilled H2O. Sections were counterstained with 
hematoxylin for 5 minutes at RT and finally dehydrated through ascending scale of alcohols and 
xylene, then mounted with coverslips using Eukitt (Sigma).  
 
3.6 Friezzle-5 immunohistochemistry 
The intestinal sections on slides are deparaffinized in xylene and hydrated through descending scale 
of alcohol. Antigen retrieval was performed by boiling sections for 10’ in 10 mM sodium citrate 
buffer (pH 6) in a microwave oven. Endogenous peroxidase was blocked by incubation with 3%  
H2O2, 50% methanol solution in PBS 2x15’ RT. Nonspecific binding was blocked for 45’ with 10% 
goat serum in PBS 1x, after which the sections were incubated with primary antibody anti-Fzd5 
(Abcam, 75234) 1:1000 in PBS for 60’ at 37°C, followed by 3 washes for 5 minutes with PBS 1x. 
After washing, the sections were incubated with biotinylated secondary antibody anti-rabbit 1:500 
(BA-1000, Vector) diluted in PBS 1x for 30’ minutes at RT. We proceeded with further washes for 
5 minutes with PBS 1x, then the sections were incubated with ABC-kit (Vector) and DAB ,Biocare 
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Medical).The development has been blocked with distilled H2O. Finally sections were dehydrated 
through ascending scale of alcohols and xylene, and then mounted with coverslips using Eukitt 
(Sigma).  
3.7 Quantitative real-time PCR 
Total RNA was extracted from adipose and small intestine tissues using PureZol RNA Isolation 
Reagent (Bio-Rad, Hercules, CA, USA) and incubated for 15 minutes. RNA was separated with 
chloroform and centrifuged for 15 minutes at 4°C, 12000g; then aqueous phase was separated and 
isopropanol was added to precipitate RNA. Pellet of RNA was cleaned with ethanol 75%, 
recentrifuged and dissolved in RNAase free water. The cDNAs were synthesized using High 
capacity cDNA Reverse Transcription Kit and the gene expressions were quantified using the 
TaqMan Master Mix and the Viia7 Real-time PCR machine (Applied Biosystems, Foster City, CA, 
USA) in accordance with manufacturer’s instructions. Primer sets for individual genes were 
purchased from Applied Biosystems. 18S was used as a housekeeping gene, levels of which did not 
change with the various diets or genotypes. Relative amounts of the target gene were calculated 
using the ΔΔCt method. The primers sets used are listed in table 1.   
Primer code 
CD3 Mm00599684_g1 
Foxp3 Mm00475162_m1 
RoRgt Mm01261022_m1 
CD4 Mm00442754_m1 
F4-80 Mm00802529_m1 
IL-6 Mm00446190_m1 
IL-10 Mm00439614_m1 
IL-12 Mm00434174_m1 
IFN-γ Mm01168134_m1 
IL-4 Mm00445259_m1 
IL-13 Mm00434204_m1 
TNF-α Mm00443258_m1 
CCL2 Mm00441242_m1 
18S Mm03928990_g1 
HIF1-
α 
Mm00468869_m1 
 
Tab.1: List of primers. 
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3.8 Oral Glucose tolerance test (OGTT) 
This test provides information on how the body copes when exposed to high blood glucose levels.  
OGTT was determined after oral glucose load at a dose of 1 g/kg body weight by oral gavage. 
Blood glucose was measured at intervals of 0, 30, 60 and 120 min using Accu-check glucometer 
(Roche diagnostics). 
 
3.9 Insulin assay 
Serum insulin concentration was measured by ELISA (EZRMI-13K, mouse/rat insulin ELISA kit, 
Millipore, MA) according to the manufacturer’s instructions. Briefly, 10µl of serum samples were 
added into each well and incubated at RT with Detection Antibody for 2 h followed by repeated 
washes. Substrate was added for 10 min and absorbance was measured at 450 nm. Standard samples 
provided with the kit were prepared and used to generate a calibration curve to interpolate sample 
data values. Insulin content in control and treated samples was expressed as ρg/ml.  
 
3.10 IL-6 ELISA assay 
Serum IL-6 concentration was measured by ELISA (DY406 ELISA kit, R&D System) according to 
the manufacturer’s instructions. Briefly, 50 µL per well of the Capture antibody were used to coat 
the 96-well microplate, and incubated overnight at RT. After wash, 100 µL of sample or standards 
were added in Reagent Diluent per well. The plate was covered with an adhesive strip and 
incubated 2 hours at RT, followed by aspiration/wash. 100 µL of the Detection Antibody was added 
to each well and incubated 2 hours at RT, followed by aspiration/wash. 100 µL of the working 
dilution Streptavidin-HRP was added to each well and incubated for 20’RT. After the 
aspiration/wash 100 µL of the Substrate Solution was added and incubated for 20’RT, followed by 
50 µL of Stop Solution. The optical density was determined using a microplate reader set to 450 
nm. Standard samples were used to generate a calibration curve to interpolate sample data values. 
IL-6 content in control and treated sample was expressed as ρg/ml. 
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3.11 Glucose Assay kit 
Serum glucose concentration was measured by the Glucose Assay Kit according to the 
manufacturer’s instructions. Serum can be directly diluted in Glucose Assay Buffer. Typically 0.5-2 
µl/assay is sufficient (normal serum contains ~5 nmol glucose/µl). 50 µl/well of reaction mix is 
required, and should contain the following components: 46 µl of Glucose Assay Buffer, 2 µl of 
Glucose Probe and 2 µl of Glucose Enzyme Mix. The reaction mix was added to each well 
containing a diluted Glucose Standard or test samples and incubated 30 min at 37°C, protect from 
light. The optical density was determined using a microplate reader set to 570 nm. Glucose 
concentrations of the test samples were calculated based on the standard curve generated. 
 
3.12 Quantification of adipocytes size 
Tissue sections from mesenteric adipose tissue were stained with H&E. Five fields for each mouse 
sections were included in the analysis. ImageJ software was used to measure adipocytes area, which 
is represented as µm
2
.  
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4. RESULTS 
 
4.1 Western Diet modifies small intestinal mucosa morphology in TLR KO mice 
 
Diet is considered one of the main factors contributing to the diversity of gut microbiota. As 
TLRs/NLRs recognize bacterial products, there is a possibility that changes in bacterial composition 
induced by diet can promote a different response by TLRs/NLRs and thus may increase 
susceptibility to intestinal inflammation. Although several studies reported that Western Diet 
induces intestinal neoplastic lesions when fed to wild-type mice for 1 year, there are no studies 
regarding TLR/NLR KO mice. In order to elucidate a putative role for TLRs/NLRs in triggering 
events that lead to alteration of the small intestinal mucosa associated to consumption of western 
diet (WD), we utilized C57BL6/J wild-type (WT) mice and TLR/NLR KO mice (TLR2, 4, 9 and 
NOD2 KO mice) fed with standard diet (SD) or WD for 3, 6 and 12 months. Body weight was 
monitored weekly (Fig.1) and histological analyses were performed in small intestinal sections in 
order to investigate the effect of WD on the morphology of the small intestine (Fig.2).  
After 3 months the body weight in WT group fed with SD remained constant around 20 g/mouse 
(left graph, fig.1A).All mice on WD, except TLR2 KO-WD, gained more body weight than mice 
fed with SD (right graph, fig.1A). In particular, there was a significant difference between WT and 
NOD2 KO fed with WD compared to WT and NOD2 KO mice fed with SD (Fig.1B). 
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Fig.1: Trend (A) and statistical analysis (B) of body weight of WT and KO mice fed with SD and WD. (*) 
indicates WD-fed animals. 
 
Anatomo-pathological observations revealed that WT mice fed with WD did not show any 
morphological alteration compared with WT mice fed with SD. Among TLR 2, 4, 9 and NOD 2 KO 
mice fed with WD, the group showing more significant alterations including villus atrophy and 
crypt disorganization were the TLR9 KO mice. In contrast, NOD2 KO mice showed a normal 
mucosa as compared to NOD2 KO mice fed with SD. TLR2 and 4 KO mice on WD showed only 
mild alterations (Fig.2). Evaluation of H/E stained sections from all KO mice fed with SD did not 
reveal changes of the mucosa architecture (Fig.2). 
We next evaluated the small intestinal morphology of WT and KO mice fed with SD and WD at six 
and twelve months of WD feeding. At six months we did not observe alterations in intestinal 
epithelial cell architecture (data not shown). The results at 12 months showed that WT mice fed 
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with SD and WT and NOD2 KO mice fed with WD spontaneusly developed small intestinal 
tumors. Unexpecdedly, we did not observe tumor formation in WD-fed TLR 9 KO mice, the groups 
displaying the most marked alterations at three months after consuption of WD (data not shown). 
Overall, the histological analysis suggests that after only three months, WD is able to induce 
alterations in the small intestinal epithelium in KO mice, in particular in  TLR9 KO.  
 
 
 
 
 
Fig.2: WD induces morphological alteration of the mucosa in TLR9 KO mice. 
Representative sections of the small intestine from wild-type and transgenic adult mice stained with 
hematoxylin/eosin (WT, TLR2 KO, TLR4 KO, TLR9 KO, NOD2 KO fed with SD; WT*, TLR2 *KO, TLR4 
*KO, TLR9* KO, NOD2* KO fed with WD) 
 
 
4.2 Western Diet affects cellular proliferation and Wnt signaling in KO mice  
Homeostasis of the intestinal epithelium is strongly dependent on the balance between cell 
proliferation, cell cycle arrest and cell differentiation. These processes are intimately coupled to cell 
migration in a precise, spatially organized manner. At the bottom of the crypts, stem cells give rise 
to a transient population of undifferentiated cells that vigorously proliferate as they migrate toward 
the lumen of the intestine. Absorptive, enteroendocrin and goblet cells migrate toward the villus 
while Paneth cells occupy the bottom of the crypts (12). We evaluated the effects of WD on small 
intestinal homeostasis. Determination of the proliferation rate of crypt cells, performed by 
immunohistochemistry for the nuclear proliferation marker Ki-67, revealed a trend for the  
reduction of proliferation in all mice fed with WD compared with mice fed with SD; this reduction 
was significant for WD-fed NOD2 KO mice (Fig.3). We next assessed proliferative cell localization 
(Fig.4). In WT mice fed with both SD (WT) and WD (WT*) proliferative cells were distributed as 
expected in the transit–amplifying zone (TA). It is noteworthy that, in KO mice fed with WD 
(TLR2*, 4*, 9* and NOD2* KO) proliferative cells are irregularly located also at the base of crypts 
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among Paneth cells, where intestinal epithelial stem cells are normally found. Moreover in TLR9 
KO mice fed with WD (TLR9*), proliferative cells are often detected in the villus epithelium 
normally occupied by differentiated cells (Fig.4). Yet all KO mice fed with SD showed a normal 
localization of proliferative cells in the TA zone as observed in WT mice (Fig.4). 
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Fig. 3: Trend for the reduction of proliferative cells in all groups of mice fed with WD. 
Mitotic cell count: WT, TLR2, 4, 9, NOD2 KO mice fed with SD; WT*, TLR2*, 4*, 9*, NOD 2* KO mice 
fed with WD. 
 
 
 
Fig.4: KO mice fed with WD show an ectopic localization of proliferative cells.  
Immunohistochemical analysis of small intestine sections stained with an antibody against proliferating cell 
antigen Ki-67. Proliferative cells were distributed as expected in intestinal crypts (TA) of the WT and KO 
mice fed with standard diet (black arrow), but were present in an ectopic position at the base of the crypts 
among Paneth cells in KO mice fed with WD (red arrow). Moreover in TLR9 fed with WD proliferative cells 
were often detected in villus epithelium normally occupied by differentiated cells (green arrow). 
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To further understand this aberrant cell localization we decided to investigate the WNT/β-catenin 
pathway. Wnt signalling has a key role in the formation of normal crypt-villus and aberrant 
activation of Wnt signaling is strongly associated with the development of intestinal cancer (19). In 
the intestine, Frizzled 5 (Fzd5), a component of WNT signaling, is necessary for regulation of 
Paneth cell differentiation and is normally confined to expression in crypt cells. Recent reports 
demonstrated that WD induces changes in villus cells that include ectopic expression of Paneth cell 
markers (a lineage normally confined to the bottom of small intestinal crypts) and elevated 
expression of the Wnt receptor (21).We performed immunohistochemistry for Fzd5 on WT and 
TLR/NLR KO mice. Its expression, in WT and KO mice fed with both SD and WD for 3 months 
was very low at the base of the crypt (Fig.5). Interestingly, only in TLR9 KO mice fed with WD 
was Fzd5 expression detected along the villus cells (Fig.5). Relevant to these findings, Wang et al 
demonstrated that WD induces ectopic expression of Fzd5 in WT mice fed with WD for one year 
(21). It is noteworthy that we observed this alteration at three months in TLR9 KO mice. Moreover, 
aberrant expression of FZD5 in TLR9 KO mice correlates with the morphological alterations and 
the ectopic localization of proliferative cells that we observed before. These findings demonstrate 
that only three months WD are sufficient to induce alterations in the distribution of proliferating 
cells that can lead to defect in Wnt-βcatenin signaling. Importantly, these results suggest a critical 
role for TLRs, especially TLR9, in the control of small intestinal homeostasis.  
 
 
 
Fig.5: Aberrant expression of Frizzled 5 (marker of Paneth cell differentiation) in TLR9* KO mice. 
Immunohistochemical detection of Fzd 5 in mice fed with SD and WD. Fzd5 expression was detected along 
the villus cells only in TLR9* KO mice fed with WD. Fzd5 expression in WT and in TLR/NLR KO mice fed 
with both SD and WD for 3 months was very low at the base of the crypt (representative image of WT fed 
with SD).  
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4.3 Effects of Western diet on T cell gene expression  
In order to evaluate the contribution of T cells to the alterations in the small intestinal mucosa 
associated to consumption of WD, we performed quantitative real time (RT)-PCR on small intestine 
samples of WT and TLR/NLR-KO mice fed with SD compared to mice fed with WD. In particular, 
we evaluated CD3e expression, a marker of all T cells, Foxp3 expression, the transcription factor 
expressed by immunosuppressive regulatory T (Treg) cells and RoRgt expression, transcription 
factor for the pro-inflammatory Th17 cells. We observed a reduction of CD3 in all mice fed with 
WD compared to mice fed with SD, significantly so in WT, TLR2* and TLR4*KO (Fig.6A). We 
calculated the Foxp3/CD3 and RoRgt/CD3 ratio, as an indicator of the relative abundance of the 
respective T cell subpopulations. The results showed that there is a significant increase in Treg cells 
compared to the total lymphocytes population only in WT and TLR2*KO fed with WD (Fig.6B). In 
TLR2*KO and TLR4*KO fed with WD we observed a significant increase of Th17 compared to 
the total T cell population (Fig.6C). The Foxp3/RoRgt ratio showed a significant reduction of 
Foxp3 in TLR2*KO mice fed with WD (Fig.6D). 
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Fig.6: Gene expression analysis by real-time qPCR of T cell markers in small intestine of WT and KO mice 
fed with SD compared to WD.  Data were normalized according to 18S mRNA level and presented as a 
value relative to that for SD fed mice. A: CD3 decrease in all mice fed with WD, significant in WT, TLR2 
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and TLR4 KO. B: increase in Treg cells in WT and TLR2*KO fed with WD. C: increase of Th17 in 
TLR2*KO and TLR4*KO fed with WD. D: reduction of Foxp3 in TLR2*KO mice fed with WD. 
 
4.4 Effect of HFD and anti-inflammatory X73 treatment on the body weight and on metabolic 
parameters 
A loss of glucose tolerance is a key component of a pre-diabetic condition in human. Often this 
state is associated with an increase of body fat and with adipose tissue inflammation, two important 
and interconnected aspects of obesity (53).  Interventions which limit adipose tissue inflammation 
may thus represent a feasible disease-prevention strategy for obesity. For this reason, we decided to 
evaluate the effects of X73, a commercial small-molecule anti-inflammatory treatment (the 
structure of which we cannot disclose in this dissertation for Intellectual Property reasons) in a 
mouse model of diet-induced obesity (DIO).We used C57BL/6J female mice fed for three months 
with SD (10 mice) or with High Fat Diet (30 mice – see Methods for diet details). Then, for a 
further two months, the mice fed with HFD were separated in four groups as follows: 9 animals 
continued to be fed with HFD, 7 animals returned to SD, 7 animals continued to be fed with HFD 
with the addition of 30mg/kg of X73 in their drinking water and, finally, 7 returned to SD with the 
addition of 30mg/kg of X73 in their drinking water. Body weight was monitored weekly (Fig.7). 
The metabolic and inflammatory status was evaluated by histological, molecular and biochemical 
analysis in all mice.   
Mice on SD and HFD had the same body weight at the onset of the experiment (Fig.7A). The body 
weight in the SD-fed group remained constant around 20 g/mouse (fig.7A, black line). By week 5 
and for the remainder of the experiment, mice fed with HFD showed statistically significant 
increases in body weight (P<0.001) relative to the SD-fed group (fig 7A blue line). X73 treatment 
induced a statistically significant decrease in body weight in mice fed with HFD (fig.7B red line) 
compared to untreated HFD-fed controls. However, as there was a non-significant but nonetheless 
notable reduction of weight in the mice that received HFD and X73 post-diet change, we cannot 
exclude that this difference is an arbitrary effect of mouse weight variation between batches of 
mice. Indeed the rate of change of weight gain in HFD-fed, X73-treated mice did not alter, unlike 
all other groups with the exception of the HFD-fed group. As expected, mice that returned to 
standard diet displayed a statistically significant decrease in body weight compared to the HFD-fed 
group (fig.7B pink line). The group with X73 treatment that was returned to SD showed a trend 
similar to the untreated group returned to SD (fig.7B green line). From these results we conclude 
that X73 treatment in HFD-fed animals does not appear to have a biologically-relevant effect on 
weight.   
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Fig.7: Effect of X73 treatment on body weight. A: SD-fed mice (black line) and HFD-fed mice (blue line); 
B: HFD→SD (pink line); HFD→SD+X73 (green line); HFD→HFD+X73 (red line). 
 
To determine if X73 treatment improved glucose tolerance, we evaluated blood glucose and insulin 
levels in all mice using commercial kits. After three months, the HFD-fed group showed a 
significant increase in insulin level compared with mice fed with SD (fig.8A). Moreover, oral 
glucose tolerance test showed that glucose level in mice fed with HFD was significantly higher at 
all times as compared to lean control (p<0,001) (fig.8.B). Data was confirmed by measurement of 
serum glucose level (fig.8C). Next, we evaluated insulin and glucose levels after diet changing. As 
expected, mice group that returned to SD showed a significant reduction of insulin compared with 
mice fed with HFD. Similar results were observed for mice treated with X73 and fed with SD. It is 
interesting to note that X73 treatment significantly decreased hyperinsulinemia level in mice fed 
with HFD (fig.9 A-B). This reversal reached the insulin levels of SD-fed mice; the magnitude of 
this effect suggests that it is very unlikely, though not formally impossible, that the effect could 
have been due to the marginal yet significant difference in weight mentioned above. In summary, 
these results suggest that X73 treatment reverses insulin resistance in mice fed with HFD. 
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Fig.8: Serum insulin (A), Glycemic index (B) and serum glucose level (C) after three months of feeding with 
SD and HFD. 
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Fig.9: X73 treatment decrease hyperinsulinemia. Insulin level (A) and serum glucose (B) after two months of 
changing diet.  
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4.5 Histological characterization of mesenteric adipose tissue after treatment with X73 
We assessed whether the metabolic improvements induced by X73 were accompanied by alterations 
in adipose tissue morphology. Morphological analysis on adipose tissue sections stained with H/E 
revealed large adipocytes in mice fed with HFD compared with mice fed with SD (Fig.10), as 
demonstrated by measurement of adipocyte size (Fig.11). The groups that returned to SD showed 
morphology similar to the control group. It is noteworthy that X73 treatment significantly reduced 
adipocyte hypertrophy in mice fed with HFD (Fig.10,11).  
This data suggests that X73 treatment can exert anti-adiposity effects. 
 
 
 
 
 
Fig.10: Hematoxylin and eosin staining of adipose tissue samples.  
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Fig.11: Statistical analysis of adipocytes size: X73 treatment reduce adipocytes hypertrophy  
 
 
4.6 Effect of HFD and X73 treatment on the inflammatory markers  
 
Obesity is characterized by a chronic, low-grade inflammation status. In order to evaluate the effect 
of X73 treatment on inflammatory state in mesenteric adipose tissue we performed quantitative RT-
PCR on tissue samples (Fig.12). In particular we evaluated the changes in the gene expression 
profiles of the pro- and anti-inflammatory cytokines: IL-6, TNF-α, IL-13, IL-4,IL-12,INF-γ,IL-1, 
and the expression of macrophage and lymphocyte markers F4-80, CD3, CD4 and Foxp3.  
HFD led to an increase in macrophages accumulation and a significant increase of pro inflammatory 
markers only for TNF-α and a trend for IL-6, that had a significant trend for reduction after 
treatment with X73 (Fig:12A). The level of the anti-inflammatory cytokine IL-10 was also 
significantly increased in mice fed with HFD compared with mice fed with SD, with a significant 
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trend for decrease after X73 treatment.  It is noteworthy that there was also a trend for reduction of 
Th1 cytokines (IL-12 and INF-γ) in mice fed with HFD compared with mice fed with SD. Among 
Th2 cytokines, which are thought to mediate long-term adipose tissue inflammation (79) , there was 
a significant increase in IL-13 in mice fed with HFD compared with other groups, while the level of 
IL-4 was significantly higher only in SD mice (Fig:12A). This finding is novel, and sheds light into 
the differential involvement of these cytokines in adipose tissue inflammation. 
Analysis of systemic inflammation, assed by ELISA of IL-6, revealed no differences between all 
groups of mice (data not shown).  
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Fig.12: Effects of X73 treatment on the inflammatory markers. A: pro- and anti-inflammatory cytokines. 
B: macrophage and lymphocyte markers. Gene expression analysis by real-time qPCR of inflammatory 
markers and of T cell subsets in mesenteric adipose tissue. Data were normalized according to 18S mRNA 
level and presented as a value relative to that for SD fed mice. 
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5 DISCUSSION  
The intestinal mucosa, composed by a monolayer of polarized intestinal epithelial cells (IECs) 
represents an important interface between the host and the microbiota. This interaction is crucial to 
the maintenance of gut homeostasis and it is mediated by TLR/NLR signaling. Any alterations of 
this equilibrium, such as dysbiosis, could induce an aberrant immune response and increase 
susceptibility to intestinal inflammation, even intestinal cancers (1,6,7). The Western diet is 
recognized as one of the main factors responsible for modifications in the gut microbiota. Although 
several studies reported that long-term feeding with WD causes intestinal neoplastic lesions in wild-
type mice, there are no studies regarding TLR/NLR KO mice. The importance of TLR/NLR 
signaling in intestinal inflammation has been clearly shown by studies using chemically induced 
mouse models of intestinal inflammation, though their role is not well defined (69). Some evidence 
have shown a protective role of PRRs and MyD88 in intestinal inflammation, whilst others reported 
that MyD88 signaling was required for inflammation (70;71). Additionally, most of the studies have 
investigated the link between WD and colon tumors, and thus little is known about what occurs the 
small intestine (5-7).  
Here, we examined the role of TLR signaling in WD-induced small intestinal inflammation. Our 
results demonstrate that WD, after only three months, is able to induce alterations in the small 
intestinal epithelium in KO mice and PRR-deficient mice for different TLR/NLRs respond 
differentially to dietary intake. Histological analyses showed small differences in KO mice fed with 
WD.  
The group showing more significant alterations, as manifested by villus atrophy and crypt 
disorganization were the TLR9 KO mice. We demonstrate that 3 months of WD are sufficient for 
affect crypt cell proliferation in all TLR/NLRKO mice, with the difference being more marked in 
TLR9KO. Immunohistochemistry for Ki-67 shows that in TLR9 KO mice, Ki-67 positive cells 
were not restricted to the crypt region, but migrated inside the normal epithelium of the villus, 
which is normally occupied by differentiated cells. This abnormal migration may be due to defects 
in intestinal stem cell niche and could be conducive to inflammation. 
It is well known that Wnt/β-Catenin is the central cell-fate determinant along the crypt-villus axis, 
and aberrant activation of this pathway is strongly associated with the development of intestinal 
cancer (72,73). Recenty, Schwitalla et al demonstrated that inflammatory Nf-kB pathway can 
modulate Wnt-signaling leading to the differentiation of epithelial non-stem cells into tumor-
initiating cells (74). Wang et al recently showed an aberrant expression pattern for Fzd5, a Wnt 
receptor involved in Paneth cell differentiation, in wt mice fed with WD for 12 months (21). In 
contrast to the Wang study, we observed this alteration as early as only three months of WD feeding 
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in TLR9 KO mice. This finding suggests that in TLR9 KO, WD can induce either a defect in the 
localization of Paneth cells or an expression of this receptor in inappropriate epithelial cell types, 
substantially earlier than in wt animals. Our results demonstrate a critical role for TLR9 signaling in 
the maintenance of the small intestinal mucosa homeostasis.  
Our results also indicate a possible role for TLR9 in the regulation of intestinal stem cell function, 
given the effects we observed on proliferation and localization of Paneth cells in TLR9KO mice. 
Previous studies show that Paneth cells express TLR9, which is critically important in detecting 
microbial pathogens (28). Impairment of TLR9 function may facilitate the entry of bacteria into 
epithelial cells due to a defective regulation of antimicrobial production resulting in impaired 
bactericidal capacity (29).  Gut microbiota have been recently shown to impact intestinal stem cells 
(75). Given that the intestinal stem cells exist in close association with the microbiota, it stands to 
reason that signaling receptors that recognize components of the microbiota, as TLR9, may be 
present on and have effects on intestinal stem cells. 
In addition to the molecular defects restricted to the intestinal epithelium, most studies of IBD focus 
on the nature of the inflammatory response and in particular on the role of T cells (41-46).  
The intestinal epithelium is populated by a large number of T cells that perform regulatory as well 
as pro-inflammatory functions (76). Here we examined the contribution of T cells, in particular 
Treg and Th17, to the alterations in the small intestinal mucosa associated to consumption of WD.  
Treg have a role in the suppression of immune reactions and prevention of autoimmune responses, 
The Th17 subset is a recently-described proinflammatory T helper cell lineage that produces IL-17 
and IL-22 to eliminate specific types of pathogens that require a strong inflammatory response.  
However, an exaggerated Th17 response can give rise to chronic inflammation and autoimmune 
disorders (41;47). Unexpectedly, our RT-PCR results reveal a decrease of the total number of CD3 
in all WD-fed mice, as judged by the levels of their signature gene, CD3, compared with SD-fed 
mice. Interestingly, our results demonstrate a significant relative increase of Treg and Th17 with 
respect the total T cell population in WD-fed TLR2 and TLR4 KO mice. The Treg/Th17 ratio 
shows a relative reduction of the Treg subset, which was significant only in WD-fed TLR2 KO 
mice. Recent evidence demonstrates that composition of the microbiota regulates the Th17:Treg 
balance (49). Moreover, Sutmuller et al demonstrate that TLR2, but not TLR4,  controls the 
expansion and function of regulatory T cells, establishing a direct link between TLR and the 
modulation of immune response through Treg (77). Our data add support for a possible role for 
TLR2 and TLR4 signaling in the balance of anti-inflammatory versus inflammatory response in the 
gut. In the absence of absolute T cell quantification and functional experiments (suppression 
assays), it would be difficult to further define the exact nature of the effect of these two receptors.  
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Interestingly, NOD2-deficient mice fed with WD not show notable alterations. Strong evidence 
associates mutations in NOD2 gene with an increased susceptibility to intestinal inflammation, as 
seen in patients with Crohn’s disease (32). Probably, in our case, dysregulation of the NOD2 
pathway alone or three months of WD feeding are not sufficient to induce small intestinal 
inflammation in NOD2 KO mice. 
 
In summary, it is becoming increasingly evident that signalling through TLR/NLR can generate 
differential responses depending on the inflammatory status of the tissue. Our results support the 
notion that WD promotes intestinal inflammation. They also demonstrate that individual TLRs have 
differential effects in the small intestine, regulating the mucosa homeostasis and inducing 
inflammatory responses. Our data contribute to the understanding of the factors by which the 
intestinal mucosal barrier is regulated in response to external stimuli, such as WD. This may be 
useful in developing novel strategies for managing and preventing intestinal inflammation.  
 
In the second part of my work we evaluated the effects of X73, a commercial small-molecule anti-
inflammatory drug (the structure of which we cannot disclose in this dissertation for Intellectual 
Property reasons) in a mouse model of diet-induced obesity (DIO). Several studies have 
demonstrated that obesity modifies the metabolic and endocrine functions of adipose tissue and is 
closely associated with chronic, low grade inflammation (11,60-62).  
In our experiments, after three months of HFD, mice showed a significant increase in serum levels 
of glucose and insulin compared with the normal control group, indicating development of insulin 
resistance. This chronic secretion of insulin is due to tissue insensitivity to insulin signalling and a 
decreased capacity of circulating insulin to regulate glucose and lipid metabolism. It is interesting to 
note that X73 treatment reversed insulin resistance in mice that continued to be fed with HFD.  
The biological events leading to obesity are characterized by changes in cell properties of 
adipocytes and include an increase of size (60). Morphological analysis on adipose tissue sections 
stained with H/E reveal large adipocytes in mice fed with HFD compared with mice fed with SD. 
X73 reduced adipocyte hypertrophy in mice fed with HFD. This data suggests that X73 treatment 
can exert anti-adiposity effects, even though no biologically relevant change in weight was 
observed.  
In the context of insulin resistance, it is now well accepted that TNF-α, a proinflammatory cytokine, 
has a critical role in the regulation of insulin action in obesity. TNF-α blocks insulin-receptor 
signaling through inhibition of serine phosphorylation of insulin receptor substrate 1 (IRS-1), via 
the activity of the serine kinase inhibitor of nuclear factor-κβ kinase (IKK-β) (57,78). In addition to 
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TNF-α, several other inflammatory mediators are also overexpressed in adipose tissue (53). Our 
results show an increase of pro inflammatory marker TNF-α and IL-6 in mesenteric adipose tissue 
of HFD-fed mice, that is significantly reduced after treatment with X73.  
Analysis of systemic inflammation, assed by ELISA of IL-6, revealed no differences between all 
groups of mice. We thus conclude that the inflammatory response that emerges in this mouse model 
of obesity resides predominantly in adipose tissue.  
Similar to other studies (58,59), HFD induced an increase of the macrophage gene expression 
marker F4-80, which was significantly decreased in X73-treated HFD-fed mice. In particular, 
several lines of evidence reported that diet-induced obesity (DIO) leads to increased macrophage 
infiltration and shifts toward the classical pro-inflammatory (M1) state. M1 macrophages aggregate 
around necrotic adipocytes, forming “crown-like structures” and produce pro-inflammatory 
cytokines perpetuating WAT inflammation and dysfunction contributing to the induction of insulin 
resistance (60). However, Fujisaka et al have demonstrated that the number of M2 macrophages 
was also increased in mice fed with HFD (61). We found that the expression of the anti-
inflammatory cytokine IL-10 is also increased significantly in adipose tissue of HFD-fed mice 
compared with SD-fed mice.  
It is noteworthy that there was a trend for the reduction of Th1 cytokines (IL-12 and INF-γ) in mice 
fed with HFD compared with mice fed with SD. On the other hand, Th2 cytokine IL-13 was 
increased in mice fed with HFD compared with other groups, while the level of IL-4 was high only 
in SD mice. This novel evidence supports and further clarifies the findings of Fujisaka et al.  
Recent data by Kwon and coworkers demonstrated that although IKKβ is a central signal transducer 
that controls the expression of proinflammatory mediators, it also induces the expression of IL-13, 
which may be limiting adipose tissue inflammation (79). Our findings are compatible with these 
results; the emerging conclusion is that long-term adipose tissue inflammation may be switching to 
a Th2-polarized phenotype, rather than Th1, as originally proposed by several studies. This would 
be more compatible with the increased tumor susceptibility associated with high calorie diet, given 
the pro-tumoral associations of type 2. 
In conclusion our results demonstrate that X73 not only displays anti-adiposity effects by improving 
reducing adipocyte hypertrophy and reversing insulin resistance, but it also modulate adipose tissue 
inflammation. In the future, this project shall be extended in order to find the mechanism of action 
of X73 and improve the understanding of the immunological pathways and factors that initiate, 
regulate, and amplify the inflammatory cascade during obesity. This, we hope, will aid the 
optimization of clinical interventions and lifestyle changes aimed at improving human health. 
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